Life Sciences Consulting -> Biotech/Healthcare VC: Best, Most Efficient Path?

Current junior in college here at a non-target, studying public health (non-finance related degree). Recently landed a summer 2026 internship at a top boutique Life Sciences Consulting firm, and I am curious about where to go from here (contingent on getting a return offer). My end goal is definitely to end up at a biotech/HC VC firm, as I am deeply interested in both the science of medicine and the business/finance side of it as well. I was originally considering going to medical school, but I am now re-evaluating this pursuit, as med school admissions continue to become more competitive, and I am concerned that not going to a best-of-the-best med school would hurt my chances of ending up in VC. Looking for some feedback from others that have gone down a similar path; is it possible to break into biotech/HC VC from life sciences consulting without an MD? If I do end up deciding to go to med school, would it be feasible to try and do a VC fellowship in my gap year, or would I be better off trying to recruit for MBB for the gap year and then VC after med school? Additionally, what other exit options would be possible from here (healthcare-focused HF, IB, PE)?

Any feedback would be appreciated!

2 Comments
 

Breaking into biotech/healthcare VC from life sciences consulting is possible, but it requires strategic planning and leveraging your experiences effectively. Based on the most helpful WSO content, here’s a roadmap and insights tailored to your situation:

1. Life Sciences Consulting as a Launchpad

  • Your summer internship at a top boutique Life Sciences Consulting firm is a strong start. Consulting roles, especially in life sciences, provide exposure to the healthcare and biotech industries, which is valuable for VC.
  • If you secure a return offer, focus on gaining experience in projects related to biotech, pharmaceuticals, or healthcare innovation. This will help you build a narrative around your interest in the intersection of science and business.

2. Breaking into Biotech/Healthcare VC Without an MD

  • While an MD or PhD is often preferred for early-stage biotech VC roles, it’s not an absolute requirement. Networking and demonstrating a strong understanding of the biotech landscape can help bridge the gap.
  • Consider pursuing an MBA or a master’s degree in a related field (e.g., biotechnology, public health with a business focus) to strengthen your credentials if you don’t go the MD route.
  • Focus on building relationships with biotech VCs through networking events, informational interviews, and internships. Highlight your consulting experience and ability to analyze investments and market opportunities.

3. VC Fellowships and Gap Year Options

  • If you decide to pursue med school, a VC fellowship during your gap year could be a great way to gain direct exposure to the industry. However, these fellowships are competitive, and you’ll need to demonstrate a strong understanding of biotech investing and a passion for the field.
  • Alternatively, recruiting for MBB consulting during your gap year is a solid option. MBB firms are highly regarded by VCs, and the experience will further develop your strategic thinking and problem-solving skills.

4. Exit Options from Life Sciences Consulting

  • Healthcare-Focused Hedge Funds (HF): Transitioning to a healthcare-focused HF is possible, especially if you develop expertise in evaluating biotech companies and market trends.
  • Investment Banking (IB): Joining a healthcare IB group can provide transaction experience and industry exposure, which are valuable for VC.
  • Private Equity (PE): While less common, healthcare-focused PE roles are an option, particularly if you gain experience in M&A or growth equity within the healthcare sector.

5. Key Strategies for Biotech/Healthcare VC

  • Networking: Build relationships with professionals in the biotech VC space. Attend industry conferences, join relevant LinkedIn groups, and connect with alumni from your consulting firm.
  • Develop Investment Skills: Practice stock pitches and learn to evaluate biotech companies. Engage with scientists and doctors to deepen your understanding of the science behind the investments.
  • Target the Right Firms: Focus on firms that are open to hiring candidates without advanced scientific degrees. Late-stage VC funds or growth equity funds may be more flexible in this regard.

6. Med School Considerations

  • If you’re still considering med school, keep in mind that attending a top-tier institution can enhance your credibility in biotech VC. However, it’s not the only path, and the time and financial investment should be weighed carefully.
  • If you choose med school, aim to gain business or investing experience during your studies (e.g., internships, fellowships) to maintain momentum toward your VC goal.

Final Thoughts

Your current path in life sciences consulting is a strong foundation for a career in biotech/healthcare VC. Whether you pursue med school, an MBA, or continue in consulting, the key is to build a compelling narrative around your passion for biotech and your ability to bridge the gap between science and business.

Sources: Biotech finance: from IB to VC / HF to funded startup, Healthcare / Biotech Venture Capital?, Confused Scientist: Where do I fit in? Strategy Consulting, Venture Capital, et al.

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Voluptatibus consequatur distinctio sit officiis nihil. Sint dignissimos exercitationem et rem amet ut. Mollitia et atque temporibus qui et ex similique placeat. Expedita qui qui consequatur quis pariatur voluptatibus non.

Expedita commodi quia laboriosam omnis quidem esse unde. Et dicta placeat quis suscipit tempore eveniet aliquam eos. Voluptatem consectetur et quia inventore assumenda quia reiciendis quo. Temporibus libero at non sapiente aperiam. Molestiae dolor nobis rem. Et sunt optio esse.

Officia harum tempora ratione autem recusandae et. Natus fugiat accusantium quod inventore. Dolore maxime cum sequi quas dolore. Laborum quae neque molestiae et. Fugiat tempora molestiae in qui dolore cum ratione.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (68) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
GameTheory's picture
GameTheory
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”